Quadriceps arthrogenic muscle inhibition: neural mechanisms and treatment perspectives.
Level 5 - mechanism / opinion, no new human data
Narrative literature review outlining mechanisms and clinical interventions without systematic synthesis
PubMed 19954822 · doi:10.1016/j.semarthrit.2009.10.001
What was done
The authors searched multiple electronic databases (AMED, CINAHL, MEDLINE, OVID, SPORTDiscus, and Scopus) to summarize the neural mechanisms causing quadriceps arthrogenic muscle inhibition (AMI) after knee injury, surgery, or arthritis, and to review potential therapeutic interventions to overcome it.
What was found
The abstract reports no numerical data or effect sizes. It describes AMI as being driven by altered articular receptor discharge secondary to swelling, inflammation, laxity, and afferent damage. Involved spinal pathways include the group I nonreciprocal (Ib) inhibitory pathway, flexion reflex, and gamma-loop, alongside preliminary evidence for supraspinal involvement. Interventions identified to reduce AMI include cryotherapy, transcutaneous electrical nerve stimulation (TENS), neuromuscular electrical stimulation (NMES), and anti-inflammatory agents (NSAIDs and intra-articular corticosteroids) when active joint inflammation exists.
Why it matters
Persistent quadriceps inhibition impedes rehabilitation after knee injuries and joint disease; understanding specific reflex and sensory pathways helps guide targeted adjunctive modalities to restore muscle activation.
Limits
The abstract provides no study counts, inclusion criteria, or quantitative synthesis. As a narrative review, it does not assess study quality or risk of bias, and relies heavily on mechanistic reasoning rather than pooled outcome data.
Cited by
- supports Pain and structural damage inhibit the central nervous system from maximally activating and recruiting muscles.